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Purpose: To identify the genetic defects underlying retinitis pigmentosa (RP) in Pakistani families.
Methods: Genome-wide high-density single-nucleotide-polymorphism microarray analysis was performed using the
DNA of nine affected individuals from two large families with multiple consanguineous marriages. Data were analyzed
to identify homozygous regions that are shared by affected sibs in each family. Sanger sequencing was performed for
genes previously implicated in autosomal recessive RP and allied retinal dystrophies that resided in the identified
homozygous regions. Probands from both families underwent fundus examination and electroretinogram measurements.
Results: The tubby-like protein 1 gene (TULP1) was present in the largest homozygous region in both families. Sequence
analysis identified a previously reported mutation (c.1138A>G; p.Thr380Ala) in one family and a novel pathogenic variant
(c.1445G>A; p.Arg482Gln) in the other family. Both variants were found to be present in a homozygous state in all
affected individuals, were heterozygous present in the unaffected parents, and heterozygous present or absent in normal
individuals. Affected individuals of both families showed an early-onset form of RP.
Conclusions: Homozygosity mapping, combined with candidate-gene analysis, successfully identified genetic defects in
TULP1 in two large Pakistani families with early-onset retinitis pigmentosa.
The  major  cause  of  inherited  blindness  in  humans  is
retinitis  pigmentosa  (RP;  OMIM  268000).  The  clinical
symptoms of RP are the loss of night vision in the early phase
of disease, later followed by peripheral vision loss, tunnel
vision, and sometimes complete blindness [1]. Progression of
the  disease  is  mainly  caused  by  the  gradual  loss  of  rod
photoreceptor cells, which are mostly responsible for vision
under low light conditions, and the subsequent loss of cone
photoreceptor cells, which are involved in color vision under
bright light conditions. The clinical diagnosis is based on
fundus examination and electrophysiological analysis of rod
and  cone  photoreceptor-cell  function  by  measuring  the
scotopic  and  photopic  responses,  respectively,  using
electroretinography (ERG). The disease’s characteristics are
the presence of pigmentary deposits (bone spicules) in the
peripheral fundus, diminished or no ERG responses from rod
Correspondence to: Frans P.M. Cremers, Department of Human
Genetics, Radboud University Nijmegen Medical Centre, P.O. Box
9101,  6500  HB  Nijmegen,  The  Netherlands;  Phone:
+31-24-3613750;  FAX:  +31-24-3668752;  email:
f.cremers@gen.umcn.nl
and cone photoreceptor cells, and attenuation of the retinal
blood vessels [1].
The disease is highly genetically heterogeneous, since 55
different genes and three loci have been identified as being
associated with nonsyndromic RP (RetNet, Nov. 8, 2011). All
Mendelian forms of inheritance have been observed for RP.
Digenic forms and rare mitochondrial inheritance have also
been reported [1-4].
Tubby-like protein 1 (TULP1; OMIM 602280) belongs
to the tubby-like protein family. The TULP1 gene is located
on the short arm of chromosome 6 [5]. TULP1 is expressed
specifically in the retina [5,6], and the encoded protein is
thought  to  be  involved  in  protein  trafficking,  such  as  the
transport of rhodopsin from the inner segment to the outer
segment via the connecting cilium [7].
The  aim  of  the  current  study  was  to  identify  the
underlying genetic causes of autosomal recessive RP (arRP)
in Pakistani families by using genome-wide homozygosity
mapping and Sanger sequencing of known retinal disease
genes  in  the  homozygous  regions.  We  identified  disease-
causing mutations in TULP1 in two large families.
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Ethics committee/institutional review board approval: Before
initiating this study, approval for this work was granted by the
Ethics Committee/Institutional Review Board of the Shifa
College of Medicine/Shifa International Hospital, Islamabad,
Pakistan, and signed informed consent was obtained from all
participating individuals in both families.
Ascertainment of families and clinical analysis: Two families
from the Punjab province with individuals having night vision
and daytime vision loss were included in the study. Their
pedigrees were drawn (Figure 1A,B) using Haplopainter [8],
and  venous  blood  samples  were  collected  in  acid  citrate
dextrose-containing vacutainers (Becton Dickinson, Franklin
Lakes, NJ). Fundus examinations were done, and ERG [9]
measurements were made for probands in both families.
Figure 1. Pedigrees and TULP1 genotyping results for families A and B. A: This is the pedigree of family A in which the presence of the c.
1138A>G variant (M) was found in a homozygous state in all affected individuals. As expected for causal autosomal recessive variants,
unaffected parents are heterozygous, and normal individuals carry one or no mutant allele. B: This is the pedigree of family B in which the
presence of the c.1445G>A variant (M) was shown in a homozygous state in the 6 affected individuals, and heterozygously in an unaffected
sibling, parents and grandparents of affected persons. C: This is the sequence electropherogram showing the nucleotide change from adenine
to guanine in the proband of family A (upper panel), and sequence electropherogram of a control individual showing the wild-type adenine
(lower panel). D: This is the sequence electropherogram of the proband carrying the mutant adenine in family B (upper panel); and the sequence
electropherogram of a control individual with the normal guanine (lower panel). Probands are indicated with arrows; asterisks indicate the
individuals  that  were  tested  using  HumanOmniExpress  (>700K)  SNP  microarrays.  M/M,  homozygous  c.1138A>G  (in  family  A)  or
homozygous c.1445G>A (in family B); +/M, heterozygous mutations present; +/+, two wild-type alleles present.
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1227Genotype analysis and homozygosity mapping:  DNA was
extracted by using a standard phenol chloroform extraction
protocol [10] and stored at 4 °C. HumanOmniExpress (>700
K) single nucleotide polymorphism (SNP) microarrays from
Illumina Inc. (San Diego, CA) were employed to search for
homozygous regions in six affected individuals (Figure 1A)
in family A and three affected individuals (Figure 1B) in
family B. Genotype data were analyzed with Homozygosity
Mapper [11], an online tool for homozygosity mapping using
SNP genotyping data. Haplotype comparisons were also done
for  affected  and  normal  individuals  to  identify  the
homozygous regions that were identical in all the affected
individuals in each family.
Sequence analysis and mutation detection: Prior to Sanger
sequencing, the 15 protein-coding exons of TULP1 and their
flanking intronic sequences were amplified by PCR using
standard conditions and reagents. PCR primers were designed
with the online primer-designing tool Primer3 [12] (available
on request). Amplified PCR products were electrophoresed in
2%  agarose  gels  containing  ethidium  bromide,  and  DNA
bands were visualized on an ultraviolet transilluminator. PCR
products were purified on PCR clean-up purification plates
(NucleoFast™ 96 PCR, Cat. No. 743100.10; MACHEREY-
NAGEL, Düren, Germany), according to the manufacturer’s
protocol. Purified PCR products were subsequently used for
Sanger sequencing in an automated DNA sequencer (Big Dye
Terminator, version 3, on a 3730 DNA analyzer; Applied
Biosystems, Foster City, CA).
Sequencing results were analyzed by using Vector NTI
Advance™ 2011 software from Life Technologies/Invitrogen
(Bleiswijk,  Netherlands),  by  assembling  the  sequenced
contigs and then visualizing the aligned sequences of the
exons.
Pathogenicity assessment of identified variants:  Identified
missense  variants  were  assessed  for  possible  causality  by
using sorting intolerant from tolerant (SIFT) analysis and
polymorphism phenotyping (Polyphen).
Restriction  fragment  length  polymorphism  analysis:
Restriction  fragment  length  polymorphism  analysis  was
performed to detect the presence or absence, of the identified
mutations, in 100 ethnically matched control individuals. For
the  mutation  identified  in  family  A,  restriction  enzyme
HpyCH4III was used, whereas in family B, restriction enzyme
MspI  was  used.  In  both  families,  restriction  enzyme
recognition sites were abolished in the mutant sequences.
Purified  PCR  products  were  used  for  restriction  enzyme
digestion,  according  to  the  manufacturer’s  protocol  (New
England BioLabs, Ipswich, MA).
Evolutionary  conservation  of  amino  acids:  To  check  the
evolutionary conservation of the mutated amino acids, the
TULP1  orthologous  protein  sequences  of  the  following
species were aligned with the Vector NTI Advance™ 2011
software:  humans  (H.  sapiens,  ENSP00000229771);
chimpanzees (P. troglodytes, ENSPTRP00000007764); mice
(M.  musculus,  ENSMUSP00000049070);  dogs  (C.
familiaris,  ENSCAFP00000001922);  chickens  (G.  gallus,
ENSGALP00000009613);  frogs  (X.  tropicalis,
ENSXETP00000000899);  tetraodons  (T.  nigroviridis,
ENSTNIP00000004001);  fruitflies  (D.  melanogaster,
FBpp0088961);  honeybees  (A.  mellifera,  GB19892-PA);
roundworms  (C.  elegans,  F10B5.4),  blood  flukes  (S.
mansoni,  Smp_058730__mRNA);  and  Arabidopsis  (A.
thaliana, AT1G76900.1).
Three-dimensional structure prediction: Project HOPE [13]
was used to predict the possible structural changes in the
mutant TULP1 proteins identified in our study using a normal
TULP1 structure (PDB-file 3C5N).
RESULTS
In both families, the average age of disease onset was in the
first  decade  of  life.  Ophthalmic  examination  of  affected
individuals  from  both  families  revealed  the  presence  of
attenuated retinal vessels and the optic disc to have a waxy,
pale appearance (Figure 2). A yellow perifoveal annular ring,
a  characteristic  feature  of  individuals  carrying  TULP1
mutations, was also clearly visible in family A (Figure 2A,B).
In  family  B,  the  perifoveal  ring  was  in  the  process  of
development  (Figure  2C,D).  Upon  ERG,  scotopic  and
photopic  electrophysiological  responses  of  rod  and  cone
photoreceptors,  respectively,  were  diminished  in  affected
members of both families (Table 1). Neither nystagmus nor
eye poking were present in either family.
Genome-wide  SNP  microarray  data  of  six  affected
individuals  of  family  A  were  analyzed  with  the  help  of
homozygosity mapper, which revealed a single homozygous
region (Figure 3A) of 3.9 Mb (from 32.9 Mb to 36.8 Mb; hg19)
on  chromosome  6,  flanked  by  SNPs  rs3132131  and
rs236411. This homozygous region harbored TULP1, a gene
known  to  be  mutated  in  patients  with  Leber  congenital
amaurosis (LCA) and arRP. The sequence analysis identified
a previously reported mutation, c.1138A>G (p.Thr380Ala)
[14,15] in this family (Figure 1C).
Similarly, genome-wide SNP microarray data analysis of
three  affected  individuals  of  family  B,  resulted  in  the
identification of six homozygous regions (Figure 3B). After
haplotype  comparison,  two  regions,  a  4.8  Mb  region  on
chromosome 6 (from 33.8 Mb to 38.6 Mb, flanked by SNPs
rs9296102  and  rs7761629)  and  a  1.4  Mb  region  on
chromosome 7 (from 132.3 Mb to 133.7 Mb, flanked by SNPs
rs924368 and rs10249912), were found to be identical in all
the affected individuals. TULP1 resides in the homozygous
region on chromosome 6, and the sequence analysis revealed
a novel mutation, c.1445G>A (p.Arg482Gln; Figure 1C). The
homozygous chromosomal region on chromosome 7 did not
contain a gene previously implicated in an inherited retinal
disease such as arRP or LCA.
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1228Figure 2. Fundus photographs of affected individuals from both families and of a normal individual. A, B: Right and left fundus, respectively,
of the proband of family A (see arrow, Figure 1A), representative of the fundus appearance of all affected members of this family. Arrows
indicate yellow perifoveal annular rings. C, D: Right and left fundus, respectively, of the proband of family B (see arrow, Figure 1B).
Arrowheads point to the developing perifoveal annular rings. E, F: Right and left fundus, respectively, of a normal individual.
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1230In  families  A  and  B,  the  variants  c.1138A>G  and  c.
1445G>A,  respectively,  were  found  to  be  present  in  a
homozygous  state  in  all  affected  individual,  were
heterozygous present in the unaffected parents, and absent or
heterozygous present in normal individuals (Figure 1A,B).
Both  wild-type  nucleotides  were  shown  to  be  highly
conserved, as evidenced by their phylogenetic p value [16]
scores of 2.87 (c.1138A) and 6.10 (c.1445G) for family A and
B,  respectively.  In  addition,  the  encoded  amino  acids,
p.Thr380  and  p.Arg482,  located  in  the  C-terminal  tubby
domain, are highly conserved among different vertebrate and
invertebrate species, while in a plant (Arabidopsis), isoleucine
is present instead of threonine (Figure 4). These amino acids
are completely conserved among the tubby, TULP1, TULP2,
and TULP3 proteins [17]. SIFT predicts that both TULP1
variants are “not tolerated” whereas Polyphen predicts that
both are “probably damaging” with prediction scores of 0.827
and 1.000 for p.Thr380Ala and p.Arg482Gln, respectively.
A  three-dimensional-structure  prediction  analysis  by
project HOPE predicts that the p.Thr380Ala mutation, due to
the smaller size of the alanine residue, causes an empty space
in the protein and possible rearrangements of surrounding
residues  (Figure  5A,B).  Any  hydrogen  bonds  made  by
threonine will also be lost, because alanine is a hydrophobic
residue.  Very  close  to  Thr380  is  a  predicted  inositol
triphosphate binding site that might also be influenced by local
conformational changes. The p.Arg482Gln variant changes a
positively charged amino acid (arginine) to a neutral residue
(glutamine), which results in the loss of interactions with
negatively charged residues in its vicinity (Figure 5C). In view
of  its  location  in  the  three-dimensional  structure,  these
changes may result in a loss of external interactions.
The p.Thr380Ala and p.Arg482Gln variants were not
detected  in  100  healthy  ethnically  matched  control
individuals.
Figure 3. Homozygosity mapping results for families A and B. Homozygosity-mapper plots show the homozygous regions in the affected
individuals in both families (red lines). Homozygous regions that show identical haplotypes for all affected individuals within a family are
indicated by arrows. Panel A represents family A and panel B represents family B.
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1231DISCUSSION
In the current study, we report on two large families with
several consanguineous marriages and multiple individuals
with  early-onset  RP  that  were  found  to  carry  TULP1
mutations. Family A had 27 affected individuals who resided
in the northern part of the Punjab province. This family had a
strong  custom  of  marrying  inside  the  family.  TULP1
mutations  were  previously  reported  to  cause  LCA,  a
congenital form of severe vision impairment or blindness and
early-onset RP [14,15,18-31]. There is clinical and genetic
overlap between (early-onset) arRP and LCA [32,33], and
often it is very difficult to differentiate between these two
conditions. Mutations in Crumbs homolog 1 (CRB1), Lecithin
retinol  acyltransferase  (LRAT),  Mer  tyrosine  kinase
protooncogene  (MERTK),  Retinal  pigment  epithelium-
specific  protein,  65-KD  (RPE65),  Spermatogenesis-
associated  protein  7  (SPATA7),  and  TULP1  have  been
identified in individuals with LCA and arRP [18-21,34-47].
If a severe form of rod–cone dystrophy is observed beyond
early childhood, and when there are no features reminiscent
of LCA, such as nystagmus, or eye poking, the phenotype is
classified as early-onset RP.
Figure  4.  Conservation  of  mutated
amino  acids  among  different  species.
Amino acids identical to human tubby-
like protein 1 (TULP1) amino acids are
shaded  in  gray.  The  positions  of  the
amino  acids  in  the  respective
polypeptides are indicated.
Figure  5.  Three-dimensional  domain
architecture  of  the  tubby  domain  of
TULP1 wild-type and mutant proteins.
A:  Preferred  predicted  secondary
structure of normal tubby-like protein 1
(TULP1)  with  Thr380  and  Arg482
indicated  in  green.  In  yellow,  the
inositol triphosphate molecules that are
predicted to bind the tubby domain of
TULP1. B: Predicted structure of part of
the  p.Thr380Ala  mutant  protein  in
affected individuals of family A. The
smaller size of the alanine residue may
lead to rearrangements of surrounding
residues  and  thereby  affect  putative
inositol triphosphate binding. C: Part of
the  predicted  structure  of  the
p.Arg482Gln mutant protein found in
affected individuals of family B. The
p.Arg482Gln  variant  changes  a
positively  charged  amino  acid
(arginine)  to  a  neutral  residue
(glutamine),  which  leads  to  loss  of
interactions  with  two  negatively
charged residues in its vicinity. Wild-
type  interactions  are  indicated  with
yellow blocks.
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1232T
A
B
L
E
 
2
.
 
T
U
L
P
1
 
M
U
T
A
T
I
O
N
S
 
C
A
U
S
I
N
G
 
A
R
R
P
 
O
R
 
L
C
A
.
E
x
o
n
/
i
n
t
r
o
n
M
u
t
a
t
i
o
n
s
:
 
A
l
l
e
l
e
 
1
/
A
l
l
e
l
e
 
2
P
h
e
n
o
t
y
p
e
N
u
m
b
e
r
 
o
f
f
a
m
i
l
i
e
s
N
u
m
b
e
r
 
o
f
 
c
a
s
e
s
R
e
f
e
r
e
n
c
e
I
n
t
r
o
n
 
2
,
 
E
x
o
n
 
1
2
c
.
9
9
+
1
G
>
A
/
c
.
1
2
0
4
G
>
T
(
p
.
G
l
u
4
0
2
*
)
L
C
A
1
/
1
7
9
1
/
1
7
9
[
1
8
]
I
n
t
r
o
n
 
4
,
 
E
x
o
n
 
5
,
1
0
c
.
3
5
0
–
2
_
3
5
0
d
e
l
A
G
A
/
c
.
9
0
1
d
e
l
C
 
(
p
.
G
l
n
3
0
1
A
r
g
f
s
*
9
)
a
r
R
P
1
/
4
9
2
/
4
9
[
2
2
]
*
*
I
n
t
r
o
n
 
2
,
 
E
x
o
n
 
1
4
c
.
9
9
+
1
G
>
A
/
c
.
1
3
7
6
T
>
A
 
(
p
.
I
l
e
4
5
9
L
y
s
)
a
r
R
P
1
/
5
3
6
1
/
5
3
6
[
2
0
]
I
n
t
r
o
n
 
7
c
.
7
1
8
+
2
T
>
C
/
c
.
7
1
8
+
2
T
>
C
j
u
v
e
n
i
l
e
 
R
P
2
/
8
6
2
8
6
[
2
4
]
E
x
o
n
 
1
0
c
.
9
0
1
C
>
T
 
(
p
.
G
l
n
3
0
1
*
)
/
c
.
9
0
1
C
>
T
 
(
p
.
G
l
n
3
0
1
*
)
L
C
A
5
/
3
7
4
2
/
1
1
7
[
2
9
]
E
x
o
n
s
 
1
0
,
 
1
1
c
.
9
3
2
G
>
A
 
(
p
.
A
r
g
3
1
1
G
l
n
)
/
c
.
1
0
2
5
G
>
A
 
(
p
.
A
r
g
3
4
2
G
l
n
)
a
r
R
P
1
/
2
2
/
4
[
3
1
]
I
n
t
r
o
n
 
1
0
c
.
9
9
9
+
5
G
>
C
/
c
.
9
9
9
+
5
G
>
C
j
u
v
e
n
i
l
e
 
R
P
1
/
8
6
1
/
8
6
[
2
4
]
E
x
o
n
 
1
1
c
.
1
1
0
2
G
>
T
 
(
p
.
G
l
y
3
6
8
T
r
p
)
/
c
.
1
1
0
2
G
>
T
 
(
p
.
G
l
y
3
6
8
T
r
p
)
L
C
A
1
/
1
7
9
1
/
1
7
9
[
1
8
]
E
x
o
n
 
1
2
c
.
1
1
3
8
A
>
G
 
(
p
.
T
h
r
3
8
0
A
l
a
)
/
c
.
1
1
3
8
A
>
G
 
(
p
.
T
h
r
3
8
0
A
l
a
)
L
C
A
,
 
e
a
r
l
y
 
o
n
s
e
t
a
r
R
P
1
/
1
4
,
 
1
/
5
,
 
1
/
2
3
/
6
4
,
 
4
/
2
3
,
 
2
7
/
3
3
[
1
4
,
1
5
]
 
a
n
d
 
t
h
i
s
s
t
u
d
y
E
x
o
n
 
1
2
c
.
1
1
4
5
T
>
C
 
(
p
.
P
h
e
3
8
2
S
e
r
)
/
c
.
1
1
4
5
T
>
C
 
(
p
.
P
h
e
3
8
2
S
e
r
)
a
r
R
P
1
/
5
9
2
/
5
9
[
2
3
]
E
x
o
n
 
1
2
c
.
1
1
9
9
G
>
A
 
(
p
.
A
r
g
4
0
0
G
l
n
)
/
c
.
1
1
9
9
G
>
A
 
(
p
.
A
r
g
4
0
0
G
l
n
)
a
r
R
P
1
/
3
4
2
/
3
4
[
2
8
]
E
x
o
n
 
1
2
c
.
1
1
9
8
C
>
T
 
(
p
.
A
r
g
4
0
0
T
r
p
)
/
c
.
1
1
9
8
C
>
T
 
(
p
.
A
r
g
4
0
0
T
r
p
)
L
C
A
1
/
1
7
9
1
/
1
7
9
[
1
8
]
E
x
o
n
s
 
1
3
,
 
1
4
c
.
1
2
5
9
G
>
C
 
(
p
.
A
r
g
4
2
0
P
r
o
)
/
c
.
1
4
7
1
T
>
C
 
(
p
.
P
h
e
4
9
1
L
e
u
)
a
r
R
P
1
/
5
3
6
2
/
5
3
6
[
2
0
]
E
x
o
n
 
1
4
c
.
1
3
8
1
C
>
G
 
(
p
.
L
e
u
4
6
1
V
a
l
)
/
c
.
1
3
8
1
C
>
G
 
(
p
.
L
e
u
4
6
1
V
a
l
)
j
u
v
e
n
i
l
e
 
R
P
1
/
8
6
1
/
8
6
[
2
4
]
E
x
o
n
 
1
4
c
.
1
4
4
5
G
>
A
 
(
p
.
A
r
g
4
8
2
G
l
n
)
/
c
.
1
4
4
5
G
>
A
 
(
p
.
A
r
g
4
8
2
G
l
n
)
e
a
r
l
y
 
o
n
s
e
t
 
a
r
R
P
1
/
2
6
/
3
3
T
h
i
s
 
s
t
u
d
y
E
x
o
n
 
1
4
c
.
1
4
6
6
A
>
G
 
(
p
.
L
y
s
4
8
9
A
r
g
)
/
c
.
1
4
6
6
A
>
G
 
(
p
.
L
y
s
4
8
9
A
r
g
)
e
a
r
l
y
 
o
n
s
e
t
 
a
r
R
P
,
a
r
R
P
4
/
5
,
 
1
/
1
7
1
1
9
/
2
3
,
 
1
/
1
7
1
[
1
5
,
1
9
]
*
*
*
I
n
t
r
o
n
 
1
4
c
.
1
4
9
5
+
1
G
>
A
/
c
.
1
4
9
5
+
1
G
>
A
a
r
R
P
2
/
2
3
3
/
3
3
[
2
1
]
I
n
t
r
o
n
 
1
4
c
.
1
4
9
5
+
2
d
u
p
T
/
c
.
1
4
9
5
+
2
d
u
p
T
e
a
r
l
y
 
o
n
s
e
t
 
a
r
R
P
1
/
1
3
/
3
[
2
6
]
I
n
t
r
o
n
 
1
4
c
.
1
4
9
6
–
6
C
>
A
/
c
.
1
4
9
6
–
6
C
>
A
a
r
R
P
1
/
1
7
1
1
/
1
7
1
[
1
9
]
E
x
o
n
s
 
1
4
,
 
1
5
c
.
1
4
4
4
C
>
T
 
(
p
.
A
r
p
4
8
2
T
r
p
)
/
 
c
.
1
5
1
1
_
1
5
2
1
d
e
l
T
G
C
A
G
T
T
C
G
G
C
 
(
p
.
L
e
u
5
0
4
f
s
*
1
4
0
)
e
a
r
l
y
 
o
n
s
e
t
 
a
r
R
P
1
/
1
5
/
5
[
5
0
]
E
x
o
n
 
1
5
c
.
1
5
8
2
_
1
5
8
7
d
u
p
T
T
C
G
C
C
 
(
p
.
P
h
e
5
2
8
_
A
l
a
5
2
9
d
u
p
)
/
 
c
.
1
5
8
2
_
1
5
8
7
d
u
p
T
T
C
G
C
C
(
p
.
P
h
e
5
2
8
_
A
l
a
5
2
9
d
u
p
)
L
C
A
1
/
1
7
/
7
[
2
5
]
*
*
*
*
 
 
 
 
 
 
 
 
 
 
*
*
V
a
r
i
a
n
t
 
l
a
b
e
l
e
d
 
a
s
 
c
.
9
3
7
d
e
l
C
.
 
*
*
*
S
a
m
e
 
c
h
a
n
g
e
 
a
t
 
p
r
o
t
e
i
n
 
l
e
v
e
l
 
b
u
t
 
l
a
b
e
l
e
d
 
a
s
 
c
.
1
5
0
2
G
>
A
 
a
t
 
t
h
e
 
c
D
N
A
 
l
e
v
e
l
.
 
*
*
*
*
C
h
a
n
g
e
 
l
a
b
e
l
e
d
 
a
s
 
c
.
1
5
9
3
_
1
5
9
4
T
T
C
G
C
C
 
 
 
 
 
 
 
 
 
 
(
F
A
5
3
1
–
5
3
2
d
u
p
)
.
 
T
h
e
 
v
a
r
i
a
n
t
s
 
i
d
e
n
t
i
f
i
e
d
 
i
n
 
t
h
i
s
 
s
t
u
d
y
 
a
r
e
 
m
a
r
k
e
d
 
i
n
 
b
o
l
d
.
 
P
a
t
i
e
n
t
s
 
w
i
t
h
 
v
i
s
u
a
l
 
l
o
s
s
,
 
n
y
s
t
a
g
m
u
s
 
a
n
d
 
n
i
g
h
t
 
b
l
i
n
d
n
e
s
s
 
a
f
t
e
r
 
t
h
e
 
a
g
e
 
o
f
 
s
i
x
 
m
o
n
t
h
s
 
b
u
t
 
 
 
 
 
 
 
 
 
 
n
o
t
 
l
a
t
e
r
 
t
h
a
n
 
s
i
x
 
y
e
a
r
s
 
a
r
e
 
d
i
a
g
n
o
s
e
d
 
a
s
 
j
u
v
e
n
i
l
e
 
R
P
 
[
2
4
]
.
Molecular Vision 2012; 18:1226-1237 <http://www.molvis.org/molvis/v18/a128> © 2012 Molecular Vision
1233TULP  family  proteins  (TUB,  TULP1,  TULP2,  and
TULP3)  have  crucial  roles  in  embryonic  development  in
vertebrates and take part in the proper functioning of the
central  nervous  system  [6,48].  TULP1  is  expressed
specifically in the rod and cone photoreceptor cells [5,6], and
is involved in the transport of rhodopsin [7]. In Tulp1−/− mice,
photoreceptor degeneration precedes synaptic malfunction,
and  thus  TULP1  may  have  a  function  in  photoreceptor
synapse development [49]. A mutation of the same residue
(p.Arg482Trp)  was  earlier  found  in  combination  with
p.Leu504fsX140  in  five  affected  individuals  with  severe
early-onset RP [50].
The  structural  analyses  of  the  TULP1  C-terminal
domains of the mutant proteins suggest that the missense
mutations identified in our study might have resulted in the
destabilization  of  the  mutant  proteins,  or  might  have
influenced  the  putative  interactions  of  the  tubby  domain.
Among different species of animals and plants, p.Arg482 is
located in the signature sequence (F-[KRHQ]-G-R-V-[ST]-x-
A-S-V-K-N-F-Q) of the Tubby family of proteins, and this
signature sequence contains 11 invariant amino acids that are
highly conserved (Prosite) [5]. Replacement of the wild-type
residue with the mutant glutamine might affect the signature
sequence; this might ultimately prevent the mutant TULP1
protein from functioning normally.
In family A, the presence of a typical yellow-colored
perifoveal  annular  ring  was  also  indicative  of  TULP1
involvement [24]; whereas in family B, the ring formation was
incomplete (Figure 2C,D). The bone spicules absent from
both families might still develop later in life. The age of both
individuals who were clinically evaluated was 20 years.
The previously identified mutation p.Thr380Ala has only
been reported in two unrelated Pakistani families [14,15]. Our
findings concerning this mutation in yet another Pakistani
family  suggested  that  c.1138A>G  might  be  a  Pakistani
founder mutation, although no link was established between
any of these families. One family belonged to a northern area
of Pakistan [14] while the other belonged to the southern part
of Punjab [15]. Our family belonged to the northern part of
Punjab, which, however, does not exclude the possibility that
this mutation represents a founder mutation in Pakistan.
Including our findings, 26 different TULP1 mutations
have  been  identified  in  33  families  (Table  2).  TULP1
mutations  were  found  in  4.3%  (10/231)  of  LCA  families
[14,18,24,25,27,29,30] and 2.4% (23/948) of arRP families
[15,19-24,26,28,30,31,50]. TULP1 mutations causing arRP or
LCA include two nonsense, two frame-shift, and seven splice-
site mutations; a six-base-pair duplication; and 14 missense
mutations  (Table  2).  Splice-site  and  protein-truncating
mutations are distributed throughout the gene (Figure 6A),
whereas the missense mutations are only present in the C-
terminal tubby domain of TULP1 (Figure 6B).
TULP1 mutations are a frequent cause of LCA and arRP,
and therefore represent an attractive therapeutic target. Thus
far,  TULP1  mutations  have  been  found  in  a  total  of  136
individuals with LCA or arRP (Table 2). Through our studies,
33 additional patients with TULP1 mutations might benefit
from  genetic  counseling  and  future  gene-augmentation
therapy.
In conclusion, we were able to identify one novel (c.
1445G>A; p.Arg482Gln) and one previously identified (c.
1138A>G;  p.Thr380Ala)  disease-causing  mutation  in
TULP1 in Pakistani families with early-onset RP.
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